A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML	Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute myeloid leukemia, bone marrow disorder, chronic myelomonocytic leukemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukemia, myelodysplastic syndrome, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasm	Active, not recruiting	Phase 1 / Phase 2	2025-05-18		NCT04730258

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Treadwell Therapeutics, Inc	2

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
City of Hope	Duarte	United States	238
New York Presbyterian Weill Cornell Medical Center	New York	United States	1
Norton Cancer Institute - Saint Matthews	Louisville	United States	4
Princess Margaret Cancer Center	Toronto	Canada	2
Queen Mary Hospital	Hong Kong	Hong Kong	96
The Ohio State University Comprehensive Cancer Center	Columbus	United States	29
The University of Texas MD Anderson Cancer Centre	Houston	United States	2
University of Alberta	Edmonton	Canada	3
University of California Davis Comprehensive Cancer Center	Sacramento	United States	299